Nanoparticles: The industrial viewpoint. Applications in diagnostic imaging;Nanoparticules : le point de vue d'un industriel. Applications en imagerie diagnostique

Annales Pharmaceutiques Francaises

Volumn 66, Issue 5-6, 2008, Pages 263-267

  Bonnemain, B ^a  

^a Laboratoire Guerbet   (France)

Author keywords

Atheroma plaques; Cancer; Degenerative diseases; Imaging; Iron oxide; Lymph nodes; MRI; Nanoparticles; Superparamagnetism

Indexed keywords

BIOLOGICAL MARKER; DEXTRAN; DEXTRAN DERIVATIVE; FERRISTENE; FERUCARBOTRAN; FERUMOXSIL; POLYSTYRENESULFONIC ACID; SILICONE; SUPERPARAMAGNETIC IRON OXIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; CONTRAST MEDIUM; FERUMOXTRAN-10; IRON DEXTRAN; MAGNETITE; MAGNETITE NANOPARTICLE; NANOPARTICLE;

ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; DEGENERATIVE DISEASE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DRUG FORMULATION; DRUG HALF LIFE; DRUG UPTAKE; GASTROINTESTINAL DISEASE; GRAFT REJECTION; HUMAN; LIVER INJURY; LYMPH NODE; MACROPHAGE; MAGNETIC FIELD; MALIGNANT NEOPLASTIC DISEASE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PARTICLE SIZE; RHEUMATOID ARTHRITIS; SHORT SURVEY; STROKE; CARDIOVASCULAR DISEASES; CHEMISTRY; DIAGNOSTIC USE; GASTROINTESTINAL DISEASES; NEOVASCULARIZATION, PATHOLOGIC; PROCEDURES;

CARDIOVASCULAR DISEASES; CONTRAST MEDIA; DEXTRANS; FERROSOFERRIC OXIDE; GASTROINTESTINAL DISEASES; HUMANS; IRON-DEXTRAN COMPLEX; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; NANOPARTICLES; NEOVASCULARIZATION, PATHOLOGIC; PARTICLE SIZE;

EID: 68649091750     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharma.2008.07.010     Document Type: Short Survey

References (19)

1. Kalveness J. Particulate agents. Enhanced MRI (1989), Mosby, Saint-Louis, MO pp.117-28
2. Bomati-Miguel O., Morales M.P., Tarta P., Ruiz-Cabello J., Bonville P., Santos M., et al. Fe-based nanoparticulate metallic alloys as contrast agents for magnetic resonance imaging. Biomaterials 26 (2005) 5695-5703
3. Benderbous S., Corot C., Jacobs P., and Bonnemain B. Superparamagnetic agents: physicochemical characteristics and preclinical imaging evaluation. Acad Radiol 3 (1996) S292-294
4. Schulze E., Ferrucci J.T., Poss K., Lapointe L., and Bogdanova A. Cellular uptake and trafficking of a prototypical magnetic iron oxide label in vitro. Invest Radiol 30 (1995) 604-610
5. Idée J.M., Port M., Raynal I., Schaefer M., Bonnemain B., Prigent P., et al. Superparamagnetic nanoparticles of iron oxides for magnetic resonance imaging applications. Nanotechnol Life Sci 10 (2007) 51-58
6. Saini S., Stark D.D., Hahn P.F., Wittenberg J., Brady T.J., and Ferrucci J.T. Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system. Radiology 162 (1987) 211-216
7. Kim M.J., Kim J.H., Chung J.J., Park M.S., Lim J.S., and Oh Y.T. Focal hepatic lesions: detection and characterization with combination gadolinium- and superparamagnetic iron oxide-enhanced MR imaging. Radiology 228 3 (2003) 719-726
8. Wang Y.X.J., Hussain S.M., and Krestin G.P. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and application in MR imaging. Eur Radiol 11 (2001) 2319-2331
9. Harisinghani M.G., Barentz J., Hahn P.F., Deserno W.M., Tabatabaei S., Hulsbergen van de Kaa C., et al. Noninvasive detection of clinically occult lymph node metastases in prostate cancers. N Engl J Med 348 (2003) 2491-2499
10. Barentz J., Fütterer J.J., and Takahashi S. Use of ultrasmall superparamagnetic iron oxide in lymph node MR imaging in prostate cancer patients. Eur J Radiol 63 (2007) 369-372
11. Tang T.Y., Howarth S.P., Miller S.R., Graves M.J., U-King-Im J.M., Trivedi R.A., et al. Comparison of the inflammatory burden of truly asymptomatic carotid atheroma with atherosclerotic plaques contralateral to symptomatic carotid stenosis: an ultrasmall superparamagnetic iron oxide enhanced magnetic resonance study. J Neurol Neurosurg Psychiatry 78 (2007) 1337-1343
12. Tang T.Y., Howarth S.P.S., Li Z.Y., Miller S.R., Graves M.J., U-King-Im J.M., et al. Correlation of carotid atheromatous plaque inflammation with biochemical stress: utility of USPIO enhanced MR imaging and finite element analysis. Atherosclerosis 196 (2008) 879-887
13. Dousset V., Brochet B., Caillé J.M., and Petry K.G. Enhancement of multiple sclerosis lesions with ultrasmall particle iron oxide: phase II study. Proc Intl Soc Magn Reson Med 9 (2001) 261
14. Hauger O., Delmas Y., Deminière C., Merville P., Combe C., and Grenier N. Late sinerem-enhanced MR imaging of renal diseases: a pilot study. Eur Radiol 14 (2004) 202
15. Saleh A., Schroeter M., Jonemanns C., Hartung H.P., Mödder U., and Jander S. In vivo MRI of brain inflammation in human ischemic stroke. Brain 17 (2004) 163-169
16. Corot C., Petry K.G., Trivedi R., Saleh A., Jonkmanns C., Le Bas J.F., et al. Macrophage imaging in central nervous system and in carotid atherosclerotic plaque using ultrasmall superparamagnetic iron oxide in magnetic resonance imaging. Invest Radiol 39 (2004) 619-625
17. Lutz A.M., Sermayer C., Corot C., Gay R.E., Goepfert K., Michel K., et al. Detection of synovial macrophages in an experimental rabbit model of antigen-induced arthritis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging. Radiology 213 (2004) 149-157
18. Bulte J.W.M., Zhang S.G., van Gelderen P., van Gelderen P., Herynek V., Jordan E.K., et al. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci U S A 96 (1999) 15256-15261
19. Daldrup-Link H.E., Rudelius M., Oostendorp R.A.J., Settles M., Piontek G., Metz S., et al. Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology 228 (2003) 760-767